Skip to main content
. 2020 Aug 25;147(2):579–591. doi: 10.1007/s00432-020-03361-0

Fig. 3.

Fig. 3

a Kaplan–Meier plot for (a) overall survival (OS) upon first-line palliative chemotherapy in relation to the extent of disease. a Patients with locally advanced pancreatic cancer (LAPC) had a median OS of 26.4 months and patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) a median OS of 9.4 months (p < 0.001, log rank). b Forest plot of hazard rations (HR) for Overall survival (OS) for patients with locally advanced pancreatic cancer (LAPC) including lymphocyte–monocyte ratio (LMR), neutrophil–lymphocyte ratio (NLR), C-reactive protein (CRP) and modified Glasgow Prognostic Score (mGPS). c Forest plot of hazard rations (HR) for Overall survival (OS) for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) including lymphocyte-monocyte ratio (LMR), neutrophil–lymphocyte ratio (NLR), C-reactive protein (CRP) and modified Glasgow Prognostic Score (mGPS)